EUCOPE’s Life Science Lectures – Episode Seven

17. Jul 2024 — Register here

The new EU HTA requirements: How to prepare for market launch from January 2025

Episode 7 – 17 July 2024 (16:00 – 17:00 CET)

In this webinar, EUCOPE experts will provide you with the rundown on the new EU HTA procedure, so that you are prepared for your European market launch. The new requirements will apply to all new oncology products and ATMPs launched in Europe from 12 January 2025 and the EU HTA procedure will run in parallel to the regulatory submission to the European Medicines Agency.


Join EUCOPE’s Secretary General, Alexander Natz, and Senior Manager for Public Affairs & Policy, Matias Olsen, as they provide answers to your questions, such as:

  • What products are in scope?
  • What are the timelines and important milestones?
  • What opportunities are there for early advice?
  • What are the possibilities to provide input in the assessment?
  • National selection of PICO(s), how to anticipate comparators?
  • The role of patient and clinician experts, what is the role of KOLs?

Register now!

Back to the events overview